PK/PD model for liposomal chemophototherapy

J Control Release. 2019 Mar 10:297:102. doi: 10.1016/j.jconrel.2019.02.022.

Author

Kinam Park¹

Affiliation

¹ Purdue University, Biomedical Engineering and Pharmaceutics, West Lafayette, IN 47907, USA. Electronic address: kpark@purdue.edu.

PMID: 30827365
DOI: 10.1016/j.jconrel.2019.02.022

No abstract available

Publication types

Editorial

MeSH terms

Animals
Antineoplastic Agents / chemistry
Antineoplastic Agents / pharmacokinetics*
Combined Modality Therapy
Doxorubicin / analogs & derivatives*
Doxorubicin / chemistry
Doxorubicin / pharmacokinetics
Drug Compounding / methods
Drug Liberation
Humans
Liposomes / chemistry*
Phospholipids / chemistry*
Phototherapy
Polyethylene Glycols / chemistry
Polyethylene Glycols / pharmacokinetics
Porphyrins / chemistry*
Porphyrins / pharmacology

Substances

Antineoplastic Agents
Liposomes
Phospholipids
Porphyrins
liposomal doxorubicin
Polyethylene Glycols
Doxorubicin